151 related articles for article (PubMed ID: 9316852)
1. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys.
Zhang Z; Miyoshi Y; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1396-401. PubMed ID: 9316852
[TBL] [Abstract][Full Text] [Related]
2. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
[TBL] [Abstract][Full Text] [Related]
3. Functional recovery in parkinsonian monkeys treated with GDNF.
Gash DM; Zhang Z; Ovadia A; Cass WA; Yi A; Simmerman L; Russell D; Martin D; Lapchak PA; Collins F; Hoffer BJ; Gerhardt GA
Nature; 1996 Mar; 380(6571):252-5. PubMed ID: 8637574
[TBL] [Abstract][Full Text] [Related]
4. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys.
Gash DM; Zhang Z; Cass WA; Ovadia A; Simmerman L; Martin D; Russell D; Collins F; Hoffer BJ; Gerhardt GA
J Comp Neurol; 1995 Dec; 363(3):345-58. PubMed ID: 8847404
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
6. Trophic factor distribution predicts functional recovery in parkinsonian monkeys.
Gash DM; Zhang Z; Ai Y; Grondin R; Coffey R; Gerhardt GA
Ann Neurol; 2005 Aug; 58(2):224-33. PubMed ID: 16049934
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
Lapchak PA; Gash DM; Collins F; Hilt D; Miller PJ; Araujo DM
Exp Neurol; 1997 Jun; 145(2 Pt 1):309-21. PubMed ID: 9217068
[No Abstract] [Full Text] [Related]
9. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease.
Grondin R; Gash DM
J Neurol; 1998 Nov; 245(11 Suppl 3):P35-42. PubMed ID: 9808338
[TBL] [Abstract][Full Text] [Related]
11. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.
Nutt JG; Burchiel KJ; Comella CL; Jankovic J; Lang AE; Laws ER; Lozano AM; Penn RD; Simpson RK; Stacy M; Wooten GF;
Neurology; 2003 Jan; 60(1):69-73. PubMed ID: 12525720
[TBL] [Abstract][Full Text] [Related]
13. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.
Collier TJ; Dung Ling Z; Carvey PM; Fletcher-Turner A; Yurek DM; Sladek JR; Kordower JH
Exp Neurol; 2005 Feb; 191 Suppl 1():S60-7. PubMed ID: 15629762
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats.
Cheng H; Huang SS; Lin SM; Lin MJ; Chu YC; Chih CL; Tsai MJ; Lin HC; Huang WC; Tsai SK
Brain Res; 2005 Feb; 1033(1):28-33. PubMed ID: 15680336
[TBL] [Abstract][Full Text] [Related]
16. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
[TBL] [Abstract][Full Text] [Related]
17. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury.
Iannotti C; Ping Zhang Y; Shields CB; Han Y; Burke DA; Xu XM
Exp Neurol; 2004 Oct; 189(2):317-32. PubMed ID: 15380482
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets.
Costa S; Iravani MM; Pearce RK; Jenner P
Eur J Pharmacol; 2001 Jan; 412(1):45-50. PubMed ID: 11166735
[TBL] [Abstract][Full Text] [Related]
19. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
20. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.
Patel NK; Bunnage M; Plaha P; Svendsen CN; Heywood P; Gill SS
Ann Neurol; 2005 Feb; 57(2):298-302. PubMed ID: 15668979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
